|
Published by: Frost & Sullivan
Published: May. 12, 2006
Table of Contents
1. Executive Summary 1. Executive Summary 1. Executive Summary 2. Introduction and Methodology 1. Introduction 1. Introduction 2. Methodology 1. Methodology 3. Investment Analysis and Growth Opportunities 1. Market Overview 1. Introduction 2. Cardiac Rhythm Management 3. Interventional Cardiology 4. Cardiac Surgery 2. Industry Economics 1. Industry Economics 3. Investment Analysis and Growth Opportunity 1. Investment Themes 2.Value Chain Analysis 3. Sector Scorecard 4. Company Scorecard 5. Frost & Sullivan Cardiovascular Devices Growth Monitor 4. Financial Benchmarking and Valuation 1. Frost & Sullivan Cardiovascular Devices Universe 1. Industry Classification 2. Ratio Analysis 1.Year-over-Year Sales Growth 2. Operating Margin 3. Selling General and Administrative (SGA) Expenses to Sales 4. Research and Development (R&D) to Sales 5. Revenues per Employee 6. Return on Average Assets vs. Return on Average Equity 7. Capital Expenditure (Capex) to Sales 8. Current Ratio 9. Receivable and Payable Days 10. Inventory Turnover Ratio 11.Asset Turnover Ratio 3. Common Size Analysis 1. Common Size Analysis 4. Fixed Cost Analysis 1. Fixed Cost Analysis 5.Valuations 1. Historical Valuation based on Sales andProfitability 2.Year to Date Stock Performance 3. Frost & Sullivan Cardiovascular Devices Index 4. Industry Growth Outlook 5. EPS Impact Analysis 6. Private Equity and Venture Capital Activity 6. Mergers and Acquisitions 1. Mergers and Acquisitions
List of Figures
SEGMENT 3
- Cardiovascular Devices Industry: Sector Scorecard (North America), 2005
- Cardiovascular Devices Industry: Company Scorecard (North America), 2005
- Cardiovascular Devices Industry: Growth Monitor (North America), 2005
SEGMENT 4
- Cardiovascular Devices Industry: Frost & Sullivan Cardiovascular Devices Universe (North America), 2006
- Cardiovascular Devices Industry: Year-over-Year Sales Growth (North America), 1996-2005
- Cardiovascular Devices Industry: Operating Margin (North America), 1996-2005
- Cardiovascular Devices Industry: SGA to Sales (North America), 1996-2005
- Cardiovascular Devices Industry: R&D to Sales (North America), 1996-2005
- Cardiovascular Devices Industry: Revenues per Employee (North America), 1996-2005
- Cardiovascular Devices Industry: Return on Average Assets (North America), 1996-2005
- Cardiovascular Devices Industry: Return on Average Equity (North America), 1996-2005
- Cardiovascular Devices Industry: Capex to Sales (North America), 1996-2005
- Cardiovascular Devices Industry: Current Ratio (North America), 1996-2005
- Cardiovascular Devices Industry: Receivable Days (North America), 1996-2005
- Cardiovascular Devices Industry: Payable Days (North America), 1996-2005
- Cardiovascular Devices Industry: Inventory Turnover Ratio (North America), 1996-2005
- Cardiovascular Devices Industry: Asset Turnover Ratio (North America), 1996-2005
- Cardiovascular Devices Industry: Common Size Income Statement of Pure Play Companies (North America), 2000-2005
- Cardiovascular Devices Industry: Common Size Balance Sheet of Pure Play Companies (North America), 2000-2005
- Cardiovascular Devices Industry: Fixed Cost Analysis for Pure Play Companies (North America), 2000-2005
- Cardiovascular Devices Industry: Percent Break-up of Fixed Costs (North America), 2000-2005
- Cardiovascular Devices Industry: Industry Growth Outlook (North America), 2006
- Cardiovascular Devices Industry: EPS Impact Analysis (North America), 2006
- Cardiovascular Devices Industry: Mergers and Acquisitions (North America), 2000-2005
AbstractResearch Overview
Frost & Sullivan's Medical Devices Financial Benchmarking & Analysis (FBA) service presents a broad financial outline of the medical devices industry, highlighting major market and financial trends in key growth segments. It provides a comprehensive financial analysis of leading medical devices firms to support the investment and financial analysis needs of decision makers in the marketplace. The current study within the service focuses on the following key growth sectors of the North American Cardiovascular Devices Market: cardiac rhythm management, interventional cardiology, and cardiac surgery.
Increased Consolidation and Improved Prospects for Venture Capital Investors
The North American Cardiovascular Devices Industry is characterized by a relatively fewer number of participants that are on an aggressive acquisition spree. With the acquisition of Guidant by Boston Scientific, the space is consolidating further. Moreover, smaller companies that develop technologies catering to an unmet need, or that convert a surgery from an in-patient to an out-patient setting, have historically been the takeover targets by larger companies. Against such backdrop, this study aims to address issues such as: the impact of consolidation on venture capital investments in the industry, the effect of the consolidation on the exit market for venture capitalists, the IPO market as an exit strategy for venture capital investors, and the segments that demonstrate significant growth potential and are attracting increased interest.
Rise in Number of Out-Patient Surgeries Providing Additional Investment Opportunities
There is an increasing preference in the market for minimally invasive surgeries amongst patients as well as doctors. These surgeries are associated with lesser trauma, shorter recovery time, and lesser post operative pain. Cardiologists also stand to gain from this trend, as more surgeries can be performed at a given time.Thus, any technology that could convert a surgery from an in-patient to an outpatient setting is considered to be a good investment and is welcomed by the market.
Benefits of the Service
- Comprehensive industry mapping of public and private companies
- Growth opportunities for public and private companies
- Comprehensive financial benchmarking
- Fundamental industry data and tracking
- Proprietary industry research on select markets
- Valuation and financial metrics
- Global coverage
- Confidential analyst briefings on research findings
- Unlimited analyst access
- Quarterly and ad-hoc research services
- Workshops, seminars and briefings to supplement the value of the written work
- Ability to provide input on the topics addressed and researched as part of the service
Market Sectors
Frost & Sullivan’s expert analysts thoroughly examine the following sectors in this research:
- Cardiac Rhythm Management
- Interventional Cardiology
- Cardiac Surgery
What's Included
- North American Cardiovascular Devices market segment revenues
- Industry economics, value chain analysis
- Investment themes
- Growth Monitor for over 30 companies
- Company & Sector Scorecards
- Valuations based on sales, profitability, and financial analysis
- Historical mergers & acquisitions for 5 years
- Private equity & venture capital activity
- Frost & Sullivan Medical Devices Stock Index
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2008
|